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thinning, which results in the conical shape of the cornea. 
These structural changes in the corneal layers induce opti-
cal aberrations, leading to a loss of visual acuity due to 
distorted blurred vision, which is caused by irregular astig-
matism, and high myopia (Rabinowitz 1998). Although 
KTCN is sometimes referred to as a corneal dystrophy, it 
is not included in International Classification of Corneal 
Dystrophies (IC3D) (Weiss et al. 2008) and should be dis-
tinguished from this group of corneal diseases. However, 
co-occurrence of KTCN with many types of corneal dys-
trophies, including Avellino and Fuchs dystrophies (Igar-
ashi et al. 2003; Salouti et al. 2010; Wilson et al. 2014), 
may indicate that common molecular mechanisms in the 
pathogenesis of these disorders are involved.
Among the general population, the estimated frequency 
of KTCN is 1 in 2,000 individuals (Rabinowitz 1998), 
although up-to-date data are not available. The prevalence 
of KTCN may be different according to patient ethnic ori-
gin (Gokhale 2013). The reported prevalence of the dis-
ease may also vary depending upon the different diagnos-
tic tests used in the particular studies. The early KTCN or 
forme fruste KTCN are not detectable at the slit lamp dur-
ing the anterior segment examination, and in these cases, 
assessment of the corneal topographic pattern is required to 
obtain the accurate diagnosis (Saad and Gatinel 2010). The 
first symptoms of KTCN usually appear during the second 
decade or early in the third decade of life. The pathogenic 
features of KTCN may be observed in different layers of 
the cornea (Fig. 1) (Sherwin and Brookes 2004). These 
abnormalities include changes in morphology of epithelial 
cells (Sykakis et al. 2012), deposition of iron particles in 
the epithelial basement membrane, breaks in Bowman’s 
layer (Rabinowitz 1998), and thinning of stroma correlat-
ing with loss of collagen lamellae, altered collagen fibril 
orientation, and decreased keratocytes density (Patey et al. 
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1984; Meek et al. 2005; Mathew et al. 2011). Descemet’s 
membrane ruptures were recognized in KTCN cases with 
corneal hydrops (Rabinowitz 1998). The endothelium usu-
ally is not harmed in KTCN; however, sometimes, elonga-
tion and damage of endothelial cells are observed (Jeyaba-
lan et al. 2013).
The clinical management of KTCN varies depending on 
the disease state and is focused on improvement of visual 
acuity and on the prevention of progression of the disease. 
Patients with the early KTCN may use spectacles or soft 
contact lenses. As the disease progresses, visual correc-
tion can be provided by rigid gas-permeable contact lenses, 
scleral lenses, or corneal collagen cross-linking. Some of 
the irregularities caused by mild-to-moderate KTCN may 
be also eliminated by insertion of intrastromal corneal 
ring segments. In advanced KTCN, due to progression 
of stromal thinning or scarring, corneal transplant sur-
gery becomes necessary (Vazirani and Basu 2013). Cor-
neal transplantation is required in up to 20% keratoconic 
eyes, thus KTCN is one of major causes for keratoplasty in 
developed countries (Faria-Correia et al. 2015).
Constant eye rubbing (McMonnies 2009), contact lens 
wear (Steahly 1978), atopy (Bawazeer et al. 2000), and UV 
light (Arnal et al. 2011) have been described as the major 
environmental and behavioral risk factors contributing 
to KTCN pathogenesis. Numerous genetic components, 
including familial inheritance (Naderan et al. 2016), a con-
cordance between monozygotic twins in contrast to dizy-
gotic twins (Tuft et al. 2012), and occurrence of syndromic 
KTCN (Elder 1994), indicate an evident genetic back-
ground of the disease. Whether KTCN is inherited accord-
ing to Mendel’s laws or to a non-Mendelian pattern remains 
unknown. Recent segregation analyses suggest that KTCN 
is a complex trait, likely involving multiple genes, variable 
penetrance, and environmental contributions (Kriszt et al. 
2014).
Various tools may be adopted to understand etiology 
of KTCN (Fig. 2). This paper focuses on results obtained 
using different genetic approaches, including both simple 
molecular techniques and high-throughput technologies 
with computational and statistical methods. The advantages 
and limitations of particular techniques were discussed 
based on literature and personal experience.
Linkage studies in KTCN
Linkage studies have been performed in large KTCN fami-
lies with both affected and unaffected individuals. Linkage 
analyses have led to the identification of 20 chromosomal 
regions linked to KTCN (Table 1). KTCN loci have been 
mainly determined in families of Caucasian or Hispanic 
origin, with further loci recognized in other ethnicities or 
in the populations originated from different geographical 
regions, including Ecuadorian, Arabic, Caribbean African, 
Finnish, and Northwest Tasmanian. The loci mentioned 
above have been identified for both isolated KTCN (e.g., 
3p14) and KTCN associated with other genomic diseases, 
such as Leber congenital amaurosis (e.g., 17p13), which 
is a clinically heterogeneous group of inherited childhood 
retinal degenerations (Hameed et al. 2000; Brancati et al. 
2004).
Among the previously reported chromosomal regions, 
only loci at 5q have been replicated (Tang et al. 2005; Li 
et al. 2006; Bisceglia et al. 2009; Rosenfeld et al. 2011; 
Bykhovskaya et al. 2016). One of them is 5q21.2 identi-
fied in Caucasians (Tang et al. 2005) and confirmed in Cau-
casians originated from Italy (Bykhovskaya et al. 2016). 
The second locus is 5q31.1-q35.3 identified in Ecuado-
rian KTCN family (Rosenfeld et al. 2011; Karolak et al. 
2017) that overlapped 5q31 and 5q32-q33 loci, previously 
reported in Caucasian/Hispanic and the Southern Ital-
ian population (Li et al. 2006; Bisceglia et al. 2009). The 
remaining KTCN susceptibility loci were representative for 
specific populations, small numbers of families, or most 
frequently, for single families only. This locus heterogene-
ity makes it difficult to identify genes unambiguously influ-
encing the KTCN.
Fig. 1  Schematic represen-
tation of the human eye. a 
Representation of healthy 
human eye with normal corneal 
thickness. b Structure of the 
human cornea. The cornea is 
a complex tissue comprised 
of five main layers (from the 
anterior to posterior margin): 
corneal epithelium, Bowman’s 
membrane, stroma, Descemet’s 
membrane, and endothelium. c 
Human eye with keratoconus 
with characteristic thinning and 
cone-like bulging of the cornea
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The finding of putative KTCN genes is additionally 
complicated by the fact that chromosomal intervals mapped 
by linkage analyses are usually large in size (up to sev-
eral megabases) and contain numerous candidate genes 
to be further evaluated. Mutation screening of all putative 
genes from these regions requires substantial additional 
effort; thus, post-linkage analysis is often narrowed to 
the sequencing of a few functional genes localized in the 
genetic interval between markers with the maximum LOD. 
However, functional and positional candidate genes often 
do not contain variants related to the disease phenotype.
COL8A1 (collagen type VIII, alpha 1) gene, localized 
at 3p14-q13 KTCN is a good example for that (Brancati 
et al. 2004). Collagens play an important role in corneal 
stroma organization. Col8a1 and Col8a2 knock-out mice 
demonstrated that type VIII collagen is required for normal 
anterior eye development, particularly the formation of a 
corneal stroma (Hopfer et al. 2005). Keeping this in mind, 
COL8A1 gene seemed to be the best functional candidate 
genes at 3p14-q13 KTCN locus. Interestingly, molecular 
screening of coding regions of COL8A1 has not revealed 
any potentially pathogenic variant (Brancati et al. 2004; 
Aldave et al. 2007). Similar situation was with COL4A1 
and COL4A2. Since it was known that type IV collagen 
may be involved in KTCN (Stachs et al. 2004), these two 
genes localized at 13q34 linkage region were the first 
choice targets for molecular screening. Again, the analysis 
showed no pathogenic variants (Karolak et al. 2011).
An another issue complicating finding of putative genes 
in linkage regions is the fact that promising candidate genes 
may be localized in close proximity to the highest linkage 
peak and not exactly in the peak. In an Ecuadorian family, 
variants fully segregating with the KTCN phenotype were 
identified in the IPO5 (importin 5), STK24 (serine/threo-
nine kinase 24), and DOCK9 (dedicator of cytokinesis 9) 
genes (Table 1). These genes are mapped in distance (0.12 
Mbp, 0.43 kbp, and 0.34 Mbp, respectively) to FARP1 
(FERM, RhoGEF, and pleckstrin domain-containing pro-
tein 1), for which the maximum LOD score (4.1 in multi-
point parametric linkage and 3.2 for multipoint non-para-
metric linkage) has been obtained. Interestingly, molecular 
screening of FARP1 has revealed no pathogenic variants in 
the affected members of the KTCN-014 family (Gajecka 
et al. 2009; Czugala et al. 2012). Causative genes might 
Fig. 2  Integrating biological data from multiple approaches to under-
stand keratoconus. To understand biological processes underlying 
keratoconus, integrated analysis of various biological aspects may 
be required. The figure summarizes information on numerous areas, 
including DNA sequence (genome), epigenetic modifications (epige-
nome), RNA transcripts (transcriptome), proteins (proteome), metab-
olites (metabolome), and microorganisms (microbiome). Each ele-
ment in the array contains examples of techniques and technologies 
that can be used to study particular biological aspects. List of abbre-
viations: genome-wide association study (GWAS), next-generation 
sequencing (NGS), whole-genome sequencing (WGS), whole-exome 
sequencing (WES), reverse-transcription-PCR (RT-PCR), chroma-
tin immunoprecipitation-sequencing (ChIP-Seq), RNA sequenc-
ing (RNA-seq), whole-genome bisulfite sequencing (WGB-seq), 2-D 
gel electrophoresis (2-DE), enzyme-linked immunosorbent assay 
(ELISA), nuclear magnetic resonance (NMR), mass spectrometry 
(MS), gas chromatography (GC), liquid chromatography–mass spec-
trometry (LC–MS)
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also be mapped in genomic regions with low linkage sig-
nals (Nowak et al. 2013). Screening of IL1RN (interleukin 
1 receptor antagonist) and SLC4A11 (solute carrier family 
4 member 11) at 2q13-q14.3 and 20p13-p12.2 (LOD scores 
of 2.395 and 2.409, respectively) has revealed variants 
that were observed significantly more frequently in family 
members with KTCN (Nowak et al. 2013).
Apart from the difficulties in selecting candidate genes 
for further analysis, another limitation of linkage stud-
ies is the need to ascertain a number of multigenerational 
families with many affected and unaffected individuals. 
Although some of the KTCN loci have been identified 
using linkage analysis of small KTCN families, no causa-
tive variants have been found in genes from those loci 
(Burdon and Vincent 2013). Moreover, as indicated above, 
some patients may have a forme fruste or early form of the 
disease that could not be properly recognized. Thus, some 
affected individuals might be classified as unaffected in the 
family pedigree, causing difficulties or errors in genotype-
phenotype correlations during linkage analyses.
Relationship between sequence variation 
and KTCN
An association analysis is the other approach implemented 
in KTCN genomic studies. One of the possible applications 
of this type of study is the assessment of the role of par-
ticular genetic variants in the development of KTCN. This 
method was used by Kim and colleagues to investigate the 
association between KTCN and variants in the IL1B (inter-
leukin 1 beta) promoter gene, which may be involved in 
inflammatory processes in KTCN (Kim et al. 2008). The 
first remark about inflammatory process in KTCN eyes was 
reported in 1991. Fabre and co-workers showed that cor-
neal fibroblasts presented fourfold more IL-1-binding sites 
than normal fibroblasts, suggesting that these corneal fibro-
blasts could have increased sensitivity to IL-1 compared 
with normal corneal fibroblasts (Fabre et al. 1991). IL-1 is 
critical for the inflammatory process and could participate 
in triggering apoptosis of the corneal cells, which might 
lead to the development of KTCN (Wilson et al. 1996). 
Kim and co-workers found that c.-31T>C and c.-511C>T 
genetic variants in the IL1B were associated with a sig-
nificantly increased risk of KTCN in Korean patients (Kim 
et al. 2008). Subsequent studies have also shown altera-
tions in the genes involved in IL-1-dependent processes, 
including IL1RN gene (Nowak et al. 2013). Association of 
IL-1-related single-nucleotide variants (SNVs) with KTCN 
may suggest that some inflammatory events are responsible 
for KTCN (Nowak et al. 2013).
The second application of association analysis, genome-
wide association study (GWAS), is used to identify the 
common sequence variation that contributes to a dis-
ease risk. This type of study is performed in case–control 
cohorts with hundreds or thousands individuals and allows 
for genome-wide analyses due to microarray-based SNP 
genotyping (Manolio 2010).
The first GWAS results for KTCN were reported in 2011 
by Burdon and co-workers. Analyses performed in cohorts 
from USA, Australia, and Northern Ireland have led to the 
identification of a positive association of KTCN with two 
SNPs, rs1014091 and rs3735520. These SNPs are local-
ized in both the promoter and upstream region of the HGF 
(hepatocyte growth factor) gene, which was previously 
reported as a high myopia gene in a Han Chinese popula-
tion (Han et al. 2006; Burdon et al. 2011) (Table 2). A sta-
tistically significant association between HGF and KTCN 
was also found in Australian patients showing that this 
locus might be relevant and contributed to disease suscep-
tibility (Sahebjada et al. 2014). The HGF contains binding 
sites for the cytokine IL-6, which may suggest that HGF, 
like IL1A, IL1B, and IL1RN, is involved in KTCN through 
inflammatory pathways (Burdon et al. 2011).
While some sequence variants in genes involved in IL-
dependent processes were identified, the role of inflam-
matory events in KTCN remains controversial. There is 
no evidence of systemic inflammation, and there were no 
statistically significant differences in the level of inflamma-
tory cytokines in serum between normal and KTCN indi-
viduals (Jun et al. 2011). Due to the absence of typical clin-
ical signs of inflammation in KTCN patients, KTCN was 
traditionally considered as a non-inflammatory corneal dis-
order. However, recent proteomic studies have provided a 
wide spectrum of evidence of local inflammation in KTCN 
patients, which may support the hypothesis by McMon-
nies (2015) that it may be appropriate to classify KTCN as 
a quasi-inflammatory disease. (McMonnies 2015). Galvis 
and co-workers also suggested that KTCN could be, at least 
in part, an inflammatory condition (Galvis et al. 2015).
The other GWAS has revealed the association between 
rs4954218 SNP, mapped upstream of the RAB3GAP1 gene 
(RAB3GTPase-activating protein) and KTCN in a Cau-
casian cohort from the USA (Li et al. 2012). These find-
ings were replicated in Australian Caucasian KTCN cases, 
providing additional evidence of significant association 
of rs4954218 with KTCN (Bae et al. 2013). Evidence of 
a genetic association was also found between KTCN and 
rs10519694 and rs2956540 SNPs located in the LOX (lysil 
oxidase) gene, encoding an enzyme responsible for colla-
gen cross-linking in different tissues, including the cornea 
(Bykhovskaya et al. 2012). This association was primarily 
identified in two independent case–control panels and in 
Caucasian and Hispanic families with KTCN (Bykhovs-
kaya et al. 2012), followed by a replication in Iranian 
patients (Hasanian-Langroudi et al. 2015). A most recent 
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GWAS has identified six loci associated with central cor-
neal thickness and KTCN-containing polymorphisms in 
the FNDC3B, MPDZ-NF1B, RXRA-COL5A1, COL5A1, 
FOXO1, and BANP-ZNF469 genes (Lu et al. 2013). Among 
them, MPDZ-NF1B and BANP-ZNF469 association was 
confirmed by an independent study, performed in an Aus-
tralian Caucasian cohort (Sahebjada et al. 2013). A detailed 
description of all loci reported to be associated with KTCN 
is presented in Table 2. The case–control association analy-
ses between KTCN in a Saudi Arabian cohort and particu-
lar SNPs from the genomic regions of FNDC3B, MPDZ-
NF1B, RXRA-COL5A1, FOXO1, LCN12-PTGDS, and 
BANP-ZNF469 did not reach the level of a statistically sig-
nificant association (Abu-Amero et al. 2015a). Genotyping 
of the SNPs in RAB3GAP1, FNDC3B, LOX, HGF, MPDZ-
NF1B, RXRA-COL5A1, COL5A1, FOXO1, and BANP-
ZNF469 in the Han Chinese KTCN patients revealed that 
only the SNP located in MPDZ-NF1B was associated with 
an increased risk of KTCN in this population. No signifi-
cant difference was observed between KTCN and controls 
in other SNPs including rs9938149 from BANP-ZNF469 
genomic region (Hao et al. 2015).
Despite computational and experimental developments, 
the interpretation of GWAS data is still a great challenge. 
Discovery of a causative variant is difficult especially if 
the associated sequence variant is located in a non-coding 
region or in a distance from known genes. These inter- and 
intra-genic regions of human genomes may contain regula-
tory elements, but a little is known regarding how particu-
lar variants affect their functions and how this influences 
the phenotype. Therefore, the statistically significant asso-
ciation of a particular SNP with a disease does not prove 
that this variant is actually causative for the disorder and 
further studies are required to assess its role in disease 
development.
Another limitation of GWAS analyses is the size of the 
study group. For complex traits, such as KTCN, meaning-
ful results can be obtained with several hundreds or thou-
sands of individuals with a disease phenotype. In addition, 
poor phenotypic classification or inconsistent phenotype 
exams (using different inclusion criteria in various ascer-
tainment places) in patients may lead to false positive 
associations. Moreover, significant loci often explain only 
a small proportion of the phenotypic variation, suggesting 
that rare variants may underlie the genetic causes of the 
disease. As GWAS recognizes only common risk alleles, 
the locus associated with GWAS signals may be far larger 
than assumed. Thus, a good solution for revealing rare 
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variants would be to extend the sequencing region to at 
least a few additional megabases around the GWAS signal 
(Dickson et al. 2010). Rare alleles may also be discovered 
through whole-exome sequencing (WES) or whole-genome 
sequencing (WGS) analyses, which will be discussed 
below.
Sanger sequencing mutational screening
For the last few decades, automated Sanger sequencing 
was the gold standard for human genome research. To 
date, numerous promising genes implicated in KTCN etiol-
ogy have been analyzed using this tool (Table 3). Among 
them were VSX1 (visual system homeobox 1) and SOD1 
(superoxide dismutase isoenzyme 1), the first two genes 
proposed as significant for KTCN development. The gene 
VSX1 is mapped to chromosome 20p11.2 and encodes a 
vertebrate paired-like homeodomain transcription factor. 
It is expressed in vitro and in vivo in human keratocytes 
during their differentiation into myofibroblasts in response 
to wound healing (Barbaro et al. 2006). SOD1 is involved 
in oxidative stress-related processes, which may have a 
role in the etiology of KTCN (Udar et al. 2006). While the 
potentially disease-causing variants were initially iden-
tified in both genes (Héon et al. 2002; Udar et al. 2006), 
subsequent studies have not confirmed the original findings 
(Stabuc-Silih et al. 2010). As indicated in Table 3a, VSX1 
is the most evaluated gene in KTCN studies. To unambigu-
ously determine the impact of VSX1 on KTCN phenotype, 
the phenotype of corresponding mouse knock-out mutants 
is important. Although the Vsx1 null mice were produced, 
their histological analyses did not show pathological altera-
tions in the cornea (Chow et al. 2004). Considering the lack 
of KTCN in Vsx1 knock-out mice and the absence of path-
ogenic variants in VSX1 in general KTCN population, the 
role of VSX1 in the pathogenesis of KTCN remains elusive.
Although the first two candidate genes, VSX1 and SOD1, 
were identified, many other genes have been assessed 
as causative for KTCN. However, Sanger sequencing of 
numerous genes with functional or positional relevance 
for KTCN, including VSX2 (visual system homeobox 2), 
CTSH (cathepsin H), CRABP1 (cellular retinoic acid bind-
ing protein 1), and RASGRF1 (RAS protein-specific gua-
nine nucleotide-releasing factor 1), has revealed no signifi-
cant variants in KTCN patients (Table 3b) (Hughes et al. 
2003; Liskova et al. 2010). The absence of causative KTCN 
variants in the coding regions of these genes indicates that 
rare coding variants are not involved in KTCN pathogen-
esis. While intronic variants and other regulatory elements 
were not assessed in those studies, the exact genotype–phe-
notype correlations still remain unclear.
Sanger sequencing has led to the identification of a pos-
sible KTCN-related variant, c.2262A>C in DOCK9. DOCK9 
encodes a protein that possesses guanosine triphosphate/
guanosine diphosphate exchange factor activity and specifi-
cally activates G-protein, CDC42, which is involved in intra-
cellular signaling networks (Kwofie and Skowronski 2008). 
The identified c.2262A>C substitution leads to the replace-
ment of glutamine by histidine at the highly conserved #754 
position of the protein encoded by DOCK9, indicating that 
this gene might contribute to the KTCN phenotype in the 
analyzed Ecuadorian family (Czugala et al. 2012). Recently, 
the effect of c.2262A>C substitution in exon 20 of DOCK9 
was assessed in vitro. It was demonstrated that this particular 
variant has led to a splicing defect, resulting in the changed 
ratio between two DOCK9 isoforms: a wild-type transcript 
and a transcript without exon 20 (Karolak et al. 2015).
Interestingly, c.2262A>C in DOCK9 together with other 
sequence variants localized in intronic regions of DOCK9 
(c.720+43A>G), IPO5 (c.2377-132A>C), and STK24 
(c.1053+29G>C) formed a disease-related haplotype that 
was carried by all affected individuals in the Ecuadorian 
KTCN family (Czugala et al. 2012). As mentioned above, 
the non-coding regions of genes contain many regulatory 
elements and intronic alterations, including single-nucle-
otide changes, which may trigger a deleterious effect on 
pre-messenger RNA splicing (Lomelin et al. 2010). Thus, 
it might be hypothesized that identification of additional 
three sequence variants in the 13q32 KTCN linked region 
could be non-accidental.
The ZNF469 (zinc finger protein 469) is another can-
didate gene screened in KTCN patients. The pathogenic 
mutations in ZNF469 were originally reported in patients 
with brittle cornea syndrome, a condition characterized by 
an extremely thin cornea that tends to rupture (Abu et al. 
2008). It was also showed that variants in ZNF469 might 
contribute to central corneal thickness (CCT), which is 
abnormal in a wide variety of corneal diseases, includ-
ing KTCN or corneal dystrophies (Lu et al. 2010, 2013; 
Vitart et al. 2010). The initial findings about an association 
between CCT and rs12447690 and rs9938149, mapped in 
the region upstream to ZNF469, were reported in patients 
from Australia and the United Kingdom, and then were rep-
licated in Croatian and Scottish, Indian and Malays, Cau-
casians, and in Latinos (Lu et al. 2010; Vitart et al. 2010; 
Vithana et al. 2011; Hoehn et al. 2012; Gao et al. 2013). 
The independent replication of GWAS results suggests the 
possible involvement of these common SNPs in CCT vari-
ation in the general population. As was indicated above, a 
recent GWAS for CCT and KTCN performed in the Euro-
pean and Asian populations has identified six loci that were 
strongly associated with a KTCN risk, including the locus 
upstream to ZNF469 (Lu et al. 2013).
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Table 3  Candidate genes screened in keratoconus patients that were not indicated in linkage and genome-wide association studies (data shown 
in chronological order)
Studied population Method No. of affected individuals/ 
no. of unaffected individuals 
(or no. of families)
References
(a) VSX1 as the well-studied gene in keratoconus
 Caucasian PCR-SSCP, Sanger sequencing 63/277 Héon et al. (2002)
 Italian Sanger sequencing 80/125 Bisceglia et al. (2005)
 Not described Sanger sequencing 100/0 Aldave et al. (2006)
 British, Indians, Pakistani, Africans, 
African-Caribbeans
Sanger sequencing 85 families Liskova et al. (2007)
 White population ABI allelic discrimination technology,  
PCR-RFLP
77/71 Tang et al. (2008)
 Ashkenazi Jewish Sanger sequencing 1 family Eran et al. (2008)
 Korean PCR-SSCP, Sanger sequencing 249/208 Mok et al. (2008)
 Indian Sanger sequencing 66/100 Paliwal et al. (2009)
 Slovenian Sanger sequencing 113/100 Stabuc-Silih et al. (2010)
 European Sanger sequencing 66/100 Dash et al. (2010)
 Indian Sanger sequencing 50/50 Tanwar et al. (2010)
 Indian Sanger sequencing 2/4 Paliwal et al. (2011)
 Saudi Arabia Sanger sequencing 55/50 Abu-Amero et al. (2011)
 Iranian Sanger sequencing, ARMS-PCR 112/52 Saee-Rad et al. (2011)
 Korean Sanger sequencing 53/100 Jeoung et al. (2012)
 South Indian Sanger sequencing 170/108 Verma et al. (2013)
 Caucasian, Polynesian, Indian Sanger sequencing 47/10 Vincent et al. (2013)
 Iranian PCR-SSCP, Sanger sequencing 50/50 Dehkordi et al. (2013)
 Han Chinese Sequenom Mass Array genotyping 97/101 Wang et al. (2013)
 Greek Sanger sequencing 33/78 Moschos et al. (2015)
 Indian Sanger sequencing 8 families Shetty et al. (2015)
 Polish Sanger sequencing 42/50 Karolak et al. (2016b)
Gene Studied population Method Case/control (or no.  
of families)
References
(b) Other genes analyzed in keratoconus patients
 CAST Multiethnic TaqMan genotyping 304/518 Li et al. (2013b)
 COL4A3 Slovenian SSCA, Sanger sequencing 104/157 Stabuc-Silih et al. (2009)
Han Chinese Sequenom Mass Array genotyping 97/101 Wang et al. (2013)
Greek Sanger sequencing 45/78 Kokolakis et al. (2014)
 COL4A4 Slovenian SSCA, Sanger sequencing 104/157 Stabuc-Silih et al. (2009)
Han Chinese Sequenom Mass Array genotyping 97/101 Wang et al. (2013)
Greek Sanger sequencing 45/78 Kokolakis et al. (2014)
Iranian Tetra-ARMS-PCR 112/150 Saravani et al. (2015)
 FAS Polish HRM genotyping, TaqMan genotyp-
ing
264/300 Synowiec et al. (2014)
 FASLG Polish HRM genotyping, TaqMan genotyp-
ing
264/300 Synowiec et al. (2014)
 FEN1 Polish PCR-RFLP 279/322 Wojcik et al. (2014b)
 IL1A Han Chinese Sequenom Mass Array genotyping 97/101 Wang et al. (2013)
 IL1B Korean PCR-RFLP, Sanger sequencing 100/100 Kim et al. (2008)
Han Chinese Sequenom Mass Array genotyping 97/101 Wang et al. (2013)
Japanese TaqMan genotyping 169/390 Mikami et al. (2013)
Turkish PCR-RFLP 121/121 Palamar et al. (2014)
 ILRN Turkish PCR-RFLP 121/121 Palamar et al. (2014)
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The molecular screening of ZNF469 gene identified a 
significant enrichment of potentially pathogenic heterozy-
gous alleles in ZNF469 in 12.5% of European KTCN 
patients (Lechner et al. 2014) and in 23.0% of Polynesian 
patients (Vincent et al. 2014). To determine whether genetic 
variants in ZNF469 truly contribute to the disease, the full-
length sequence of this gene was analyzed in unrelated Pol-
ish patients with isolated KTCN. Interestingly, sequencing 
revealed that average number of non-synonymous variants 
per one individual was comparable for KTCN and healthy 
Polish individuals and was 16.31 and 18.0, respectively 
(Karolak et al. 2016b). Based on the previous findings, it 
appears that the role of heterozygous variants in ZNF469 in 
KTCN patients should be further evaluated. The high prev-
alence of ZNF469 variants noted in KTCN individuals is 
typical for a common genetic variation observed in the gen-
eral population. Moreover, the high phenotypic heterogene-
ity demonstrated by ZNF469 gene mutations may indicate 
that similar processes are involved in diseases characterized 
by corneal thinning, in general, rather than only in KTCN 
(Davidson et al. 2015; Karolak et al. 2016a).
Mitochondrial studies
In addition to the numerous sequencing studies focused on 
genomic DNA, a few studies have also been conducted on 
the level of mitochondrial DNA to identify further genetic 
aspects of KTCN. An analysis of mitochondrial complex I 
genes (ND1-ND6) in 20 Indian KTCN patients has revealed 
84 variants, including two novel frameshift variants 
(Pathak et al. 2011). An investigation of full mitochondrial 
DNA extracted from blood samples of KTCN cases from 
Saudi Arabia has revealed mitochondrial DNA variants in 
38.5% of KTCN patients. Among identified changes, only 
one non-synonymous variant (m.4218T>A in ND1) was 
heteroplasmic, whereas the remaining nine were homo-
plasmic (Abu-Amero et al. 2014). Homoplasmic muta-
tions may lead to several diseases, but also heteroplasmic 
changes might be pathogenic, if the ratio between wild-
type and altered mtDNA exceeds a given threshold value. 
The high level of heteroplasmy (74%) in studies performed 
by Abu-Amero and colleagues suggests that the identified 
change in ND1 might be involved in KTCN (Abu-Amero 
et al. 2014). However, further studies are needed to deter-
mine the role of heteroplasmic changes in KTCN. As it is 
known that the traditional PCR followed by direct Sanger 
sequencing is insufficient to detect heteroplasmy, and it 
also lacks the necessary sensitivity to identify low levels of 
mosaicism (Jamuar et al. 2014; Gajecka 2016), techniques 
other than Sanger sequencing should be applied to assess 
heteroplasmy in KTCN.
Analysis of mitochondrial DNA gives insight into oxi-
dative damage in KTCN. Oxidative stress is a consequence 
of the accumulation of reactive oxygen species (ROS) in 
different compartments of human body, including cornea, 
which cause a toxic effect on a number of cellular com-
ponents, such as proteins, nucleic acids, and membrane 
phospholipids. ROS may be induced by UV light, and 
since the cornea is constantly exposed to the UV radia-
tion, it is particularly vulnerable to the oxidative stress 
and damage from ROS (Buddi et al. 2002). The healthy 
cornea has several mechanisms involved in the minimiza-
tion of ROS damaging effects, including both enzymatic 
activities and non-enzymatic pathways, which are altered 
in KTCN (Gondhowiardjo and van Haeringen 1993). It has 
been shown that besides the mitochondrial DNA damage, 
the level of antioxidants was decreased in KTCN corneas. 
Moreover, the level of oxidative stress markers was ele-
vated, which suggested that mechanisms protecting against 
oxidative stress and cell degradation might be altered in 
this disease (Arnal et al. 2011; Wojcik et al. 2014a; Toprak 
Table 3  continued
Gene Studied population Method Case/control (or no.  
of families)
References
 LIG3 Polish genotyping 283/300 Synowiec et al. (2015)
 RAD51 Polish PCR-RFLP 100/150 Synowiec et al. (2013)
 SOD1 Multiethnic Sanger sequencing 15 Probands/156 Udar et al. (2006)
Slovenian Sanger sequencing 113/100 Stabuc-Silih et al. (2010)
Iranian Sanger sequencing, ARMS-PCR 112/52 Saee-Rad et al. (2011)
Greek Sanger sequencing 33/78 Moschos et al. (2015)
Saudi Arabia Sanger sequencing 55/100 Al-Muammar et al. 
(2015)
 TF Polish PCR-RFLP 216/228 Wójcik et al. (2013)
 TGFBI American Sanger sequencing 15 Probands Udar et al. (2004)
Chinese Sanger sequencing 30/30 Guan et al. (2012)
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et al. 2014). It is unclear whether oxidative cell degrada-
tion is a primary process in the disease development or it 
is a secondary effect.
Next‑generation sequencing as a tool 
for high‑throughput data generation
As mentioned above, sequencing of numerous candidate 
genes is time-consuming and labor intensive and thus may 
be not effective in a large-scale study. These limitations can 
be reduced using next-generation sequencing (NGS). Cur-
rent NGS technologies offer different methods for template 
preparation, sequencing, visualizing, genome alignment, 
and assembly. Still, each NGS strategy allows for direct 
and complete DNA sequencing in a high-throughput man-
ner, as well as the production of an enormous volume of 
low-cost reads per instrument run (Metzker 2010). Since 
2005, NGS platforms have become widely available, giv-
ing an impressive range of applications. The general DNA 
sequencing platforms offer WGS and targeted resequencing 
(Koboldt et al. 2013).
Targeted resequencing allows for focusing on all 
genomic regions of interest in one experiment. One of 
the strategies of targeted sequencing is whole-exome 
sequencing (WES). WES is a promising tool that ena-
bles selective sequencing of nearly all protein-coding 
sequences. Unlike the gold standard—exon-by-exon anal-
ysis by conventional Sanger sequencing—WES is time- 
and cost-effective and more suitable for the precise deter-
mination of rare and unique coding sequence variants in 
an individual exome. The literature data provide many 
examples of the efficacy of WES in variants identification 
in both rare and common complex disorders, including 
ocular diseases. Rare coding sequence variants have been 
found in patients with the sporadic and the familial form 
of retinitis pigmentosa (Jinda et al. 2014; Villanueva et al. 
2014) and retinal dystrophy (Ortube et al. 2014). WES 
studies have also been successful in identifying muta-
tions in other ophthalmic diseases, including high myo-
pia (Zhao et al. 2013), cone-rod dystrophy (Huang et al. 
2013), and corneal intraepithelial dyskeratosis (Soler 
et al. 2013), while in the literature, there is only one report 
about WES in KTCN research (Karolak et al. 2017). Also, 
targeted resequencing of a subset of the human genome 
was used by Hughes and colleagues in a selective screen 
of all genes within the 5.5 Mb region of chromosome 
15q22-q25, which was previously reported as linked with 
KTCN in a Northern Irish family. That search resulted in 
the detection of c.57 C>T variant in the seed region of the 
miR-184 gene in a family with severe KTCN combined 
with the early onset anterior polar cataract (Hughes et al. 
2003, 2011).
The variants in miR-184 were also identified in four 
subsequent studies performed in two Chinese patients with 
isolated KTCN; in patients with a syndrome characterized 
by endothelial dystrophy, iris hypoplasia, congenital cata-
ract, and stromal thinning (EDICT); in members of family 
with congenital cataracts and corneal abnormalities includ-
ing KTCN, and in Greek sporadic KTCN patients (Iliff 
et al. 2012; Lechner et al. 2013; Bykhovskaya et al. 2015; 
Moschos et al. 2016). In contrast, latest studies performed 
in Iranian and Saudi Arabian KTCN patients revealed no 
significant miR-184 variants, which may suggest that alter-
ations in miR-184 are a rare cause of KTCN alone (Abu-
Amero et al. 2015b; Farzadfard et al. 2016).
WES studies are restricted to determining the variants in 
protein-coding sequences, which constitute approximately 
only 1% of the whole human genome. Thus, many poten-
tially important variants localized in the remaining parts 
of the genome would be missed. Other limitations of WES 
include both technical and post-sequencing issues. Some 
difficulties may result from insufficient sequencing cover-
age or inappropriate algorithms used for variant calling and 
annotation, especially in case of variants from multi-allelic 
sites. Despite the expanded databases and sophisticated 
workflows for data processing, both the narrowing of a 
large amount of initial data to a manageable number of var-
iants and the filtering of candidate variants without a loss 
of possible causative ones are still challenging. While trio 
analysis (patient and both parents are included) in search of 
de novo mutations is quite simple, looking for hereditable 
mutations in large families with a complex disease, such 
as KTCN, could be problematic and requires additional 
Sanger-segregation analyses. Despite these limitations, 
WES is a promising tool to study genetic causes of many 
disorders. The increasing interest in new molecular tech-
niques and easier access to the necessary equipment leads 
us to believe that this approach will be more frequently 
implemented in KTCN research in the near future.
As we indicated above, WES allows for analysis of the 
coding region of genes only. Since many DNA variants 
associated with diseases lie outside the coding regions of 
genomic DNA, WGS, which allows for the characteriza-
tion of entire genomes of any size, has become a promis-
ing and more appropriate solution for research looking for 
the unidentified genetic causes of diseases. However, while 
the newest machines can process whole human genomes 
for only $1000 each, WGS is not routinely used in research 
laboratories. An expanded computational infrastructure 
is required in processing and interpreting data sets of full 
genomes. Literature data showed that WGS may be suc-
cessfully implemented in the identification of pathogenic 
DNA variants in genetically heterogeneous diseases, 
including autism spectrum disorder and the autosomal 
recessive retinitis pigmentosa (Jiang et al. 2013; Nishiguchi 
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et al. 2013). Since locus and allelic heterogeneity has been 
observed in KTCN studies, it is reasonable to assume that 
WGS will be a useful method for assessing KTCN etiology.
Epigenetic studies
There are many changes in gene function, which are not 
elucidated by variations in the DNA sequence but may be 
explained by epigenetic modifications. Epigenetic mecha-
nisms include, i.e., DNA methylation, and regulation of 
gene expression by small and non-coding RNAs. As epige-
netic changes may be associated with the development and 
progression in several diseases, and then the epigenomic 
studies need to be added to molecular-based investigations 
of human disorders.
Methylation status in KTCN was studied in TIMP3 
(tissue inhibitor of metalloproteinase 3) promoter. It was 
shown that overexpression of TIMP3 might induce apopto-
sis in corneal stromal cell cultures leading to KTCN (Mat-
thews et al. 2007). Changes in DNA sequence of TIMP3 
were not identified suggesting that alteration of TIMP3 
expression might be due to epigenetic factors (De Bonis 
et al. 2011). However, methylation-specific quantitative 
PCR performed in three keratoconic and three healthy cor-
neal tissues excluded promoter methylation in the TIMP3 
(De Bonis et al. 2011). Large-scale epigenetic studies have 
never been implemented in KTCN research.
Challenges and outlook
• One of the issues limiting KTCN studies is a problem 
with the collection of the appropriate tissue for analyses. 
While blood samples are usually not difficult to collect 
from all studied individuals, the collection of whole cor-
neal tissues or their fragment is limited to patients with 
corneal transplantation. Moreover, it is not possible to 
obtain the healthy cornea from living donors for com-
parative analyses. Therefore, the corneal tissues are often 
derived from non-KTCN individuals with other corneal 
events, who were referred for corneal transplantation.
• A good model for KTCN research could be cell lines 
derived from different parts of human corneas, i.e., cor-
neal epithelial or endothelial cell lines, and corneal fibro-
blasts. However, the establishment and cultivation of cell 
lines are difficult and often fail. In addition, corneal cell 
lines as other cell lines derived from different cell types 
are not well characterized, have a limited life span, and 
may not reflect the properties of in vivo cells.
• There is sufficient data to suggest that KTCN has a 
strong genetic component. Based on genetic studies, 
it has become clear that KTCN etiology might involve 
more than one causing factor and the traditional molec-
ular techniques may not be sufficient for identifying 
all elements involved in KTCN. The rapid advances of 
high-throughput molecular technologies have led to the 
development of innovative approaches allowing rela-
tionship analyses between disease phenotype and vari-
ations in the human genome. With increased using of 
next-generation sequencing technologies, it may be pos-
sible to identify genetic variants underlying the KTCN 
etiology.
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